ARVINAS, INC.

ARVN Net selling

CIK 0001655759 #2976 in the set updated 19 Sep 2026

Bought (120 mo)

$69.62M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$161.24M

$66.04K on a plan · $43.80M straight out of an exercise

Sold at will

$117.37M

118 of 200 sales

Net

−$91.62M

−$47.76M against sales at will

By person

28 insiders · 240 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

SHANNON TIMOTHY M

Director

$372.83K (5)

$34.51M (25)

−$34.14M

11,211,782

17.15%

$91.48M

+70.0%

5AM VENTURES III, L.P. entity

10% owner

—

$26.56M (8)

−$26.56M

1,002

0.0015%

$8.18K

—

Houston John G

Director

$480.00K (1)

$17.74M (26) scheduled

−$17.26M

1,122,183

1.72%

$9.16M

+51.1%

RA CAPITAL MANAGEMENT, L.P. entity

Former 10% Owner

$16.00M (1)

—

+$16.00M

3,138,412

4.80%

$25.61M

—

Ratcliffe Liam

Director

$40.96M (4)

$51.37M (39)

−$10.41M

1,008,543

1.54%

$8.23M

—

Cassidy Sean A

Chief Financial Officer

$25.60K (1)

$9.32M (26) scheduled

−$9.30M

181,916

0.2782%

$1.48M

+8.4%

Taylor Ian

President, R&D

$14.66K (1)

$7.71M (27) scheduled

−$7.69M

159,121

0.2434%

$1.30M

+88.3%

Peck Ronald

Chief Medical Officer

—

$5.05M (9) scheduled

−$5.05M

67,516

0.1033%

$550.86K

—

Flynn James E

10% owner

$5.00M (3)

—

+$5.00M

1,233,734

1.89%

$10.07M

—

Loven Jakob

Director

$5.00M (1)

—

+$5.00M

1,694,351

2.59%

$13.82M

—

Margus Bradley Albert

Director

$640.00K (1)

$5.02M (5)

−$4.38M

61,463

0.0940%

$501.48K

+3.4%

Morrison Briggs

Director

$590.53K (3)

$2.77M (7) scheduled

−$2.18M

111,548

0.1706%

$910.12K

+312.8%

Kennedy Edward Moore Jr.

Director

$535.91K (2)

—

+$535.91K

54,957

0.0840%

$448.39K

—

Berkowitz Noah

Chief Medical Officer

—

$323.78K (4)

−$323.78K

191,395

0.2927%

$1.56M

—

Cacace Angela M

Chief Scientific Officer

—

$303.60K (8)

−$303.60K

180,390

0.2759%

$1.47M

+375.6%

Saik Andrew

Chief Financial Officer

—

$261.59K (4)

−$261.59K

187,432

0.2867%

$1.53M

—

Teel Randy

President and CEO

—

$226.48K (5)

−$226.48K

285,009

0.4359%

$2.33M

+96.6%

Loomis David K

VP, Chief Accounting Officer

—

$77.53K (7)

−$77.53K

40,193

0.0615%

$327.93K

+622.8%

Canaan IX L.P.

10% owner

—

—

—

3,589,554

5.49%

$29.29M

—

ELM STREET VENTURES L P entity

Former 10% owner

—

—

—

767,623

1.17%

$6.26M

—

Norwalk Leslie V

Director

—

—

—

41,572

0.0636%

$339.19K

—

Cunningham Everett

Director

—

—

—

41,572

0.0636%

$339.19K

—

Smaldone Alsup Laurie

Director

—

—

—

41,572

0.0636%

$339.19K

—

Bain Linda

Director

—

—

—

41,572

0.0636%

$339.19K

—

AGARWAL SUNIL

Director

—

—

—

30,166

0.0461%

$246.12K

—

YOUNG JOHN D

Director

—

—

—

26,045

0.0398%

$212.50K

—

DIXON WENDY L

Director

—

—

—

9,121

0.0139%

$74.42K

+82.4%

PARMAR KUSH

Director

—

—

—

1,775

0.0027%

$14.48K

—

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

Saik Andrew

24 Jun 2026

Chief Financial Officer

Sold on a plan

5,696

$8.16

$46.47K

Cacace Angela M

17 Jun 2026

Chief Scientific Officer

Sold on a plan

2,576

$7.60

$19.56K

Show all 240 transactions →

What was left out

Form 4 filings counted 243

Amendments (4/A) skipped 3

Filings about a different issuer 0

Unreadable filings 0

Joint filings 12

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 80

Sales at will 118

Transactions with no price 0

Shares from compensation/vesting 25,802,990

Sales filed before the plan box existed 81

History held since 28 Sep 2018